6-aminohexanoic acid is a lipid of Fatty Acyls (FA) class. 6-aminohexanoic acid is associated with abnormalities such as Blood Clot, Myocardial Infarction, Cerebrovascular accident, Renal impairment and Scoliosis, unspecified. The involved functions are known as Fibrinolysis, Agent, Hemorrhage, plasminogen activation and inhibitors. 6-aminohexanoic acid often locates in Chest, Blood, Body tissue, peritoneal and Plasma membrane. The associated genes with 6-aminohexanoic acid are P4HTM gene, BSND gene, MTPN gene, NDUFS4 gene and Homologous Gene. The related lipids are Phosphatidylserines and Butyric Acid.
To understand associated biological information of 6-aminohexanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
6-aminohexanoic acid is suspected in Cerebrovascular accident, Blood Clot, Myocardial Infarction, Renal impairment, Thromboembolism, Postoperative myocardial infarction and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 6-aminohexanoic acid
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Scepansky E et al. | Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas. | 2014 | Acta Haematol. | pmid:24296552 |
Kong HY et al. | Epsilon-aminocaproic acid improves postrecirculation hemodynamics by reducing intraliver activated protein C consumption in orthotopic liver transplantation. | 2014 | World J Surg | pmid:24142329 |
Verma K et al. | The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. | 2014 | J Bone Joint Surg Am | pmid:24875032 |
Cheng L et al. | Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction. | 2014 | ACS Med Chem Lett | pmid:24900876 |
Gordon ZL et al. | Bipolar sealer device reduces blood loss and transfusion requirements in posterior spinal fusion for adolescent idiopathic scoliosis. | 2013 Oct-Nov | J Pediatr Orthop | pmid:23812158 |
Fletcher DJ et al. | Therapeutic plasma concentrations of epsilon aminocaproic acid and tranexamic acid in horses. | 2013 Nov-Dec | J. Vet. Intern. Med. | pmid:24118238 |
Midura-Nowaczek K et al. | Effect of short peptides containing lysine and epsilon-aminocaproic acid on fibrinolytic activity of plasmin and topoisomerase II action on supercoiled DNA. | 2013 May-Jun | Acta Pol Pharm | pmid:23757933 |
Silva PG et al. | Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery. | 2013 Jul-Sep | Einstein (Sao Paulo) | pmid:24136757 |
Dhir A | Antifibrinolytics in cardiac surgery. | 2013 Apr-Jun | Ann Card Anaesth | pmid:23545866 |
Meybohm P et al. | Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patients. | 2013 | PLoS ONE | pmid:23483965 |